Voglibose 0.2 mg with Repaglinide 0.5 mg

Voglibose 0.2 mg and Repaglinide 0.5 mg Tablets are a combination of two medicines, Voglibose and Repaglinide. This medication is used to help manage type 2 diabetes mellitus. Voglibose belongs to the drug class known as an alpha-glucosidase inhibitor. It works by slowing down the breakdown and absorption of carbohydrates in the intestine, thereby controlling post-meal blood sugar spikes. Whereas, Repaglinide is a short and fast-acting insulin secretagogue that stimulates the pancreas to release insulin and helps regulate the amount of glucose in the blood. 

Type 2 diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose, also known as hyperglycemia. While using this medication, an individual must include a healthy diet, regular exercise, and weight reduction as advised by their doctor. This combination synergistically targets post-meal blood sugar spikes, a key challenge in diabetes control. 

Arlak Corazon is among the leading and prominent leaders of the Pharmaceutical Landscape. Delivering and manufacturing high-quality pharmaceutical products, along with Voglibose 0.2 mg and Repaglinide 0.5 mg tablets, marketed under the brand name Coravog-R0.2/0.5. The organization is backed up by a team of professionals and state-of-the-art manufacturing facilities to ensure the quality, safety, and affordability of the pharmaceutical products. 

What are the Medical Benefits of the Voglibose and Repaglinide Tablets? 

This medication is widely beneficial for patients, particularly those who require better control over mealtime blood sugar fluctuations. By reducing the post-meal glucose spike and stimulating timely insulin release, it supports overall glycemic control and lowers the risk of long-term diabetes-related complications.

Mentioned below is the list of medical benefits provided by Voglibose and Repaglinide Tablets.

• It helps manage type 2 diabetes mellitus effectively.
• Also, reduces post-meal blood sugar levels.
• Voglibose and Repaglinide Tablets prevent sharp glucose fluctuations.
• Lowers risk of diabetes-related complications.
• Supports long-term glycemic control.
• This tablet indirectly contributes to reducing the long-term risk of cardiovascular complications associated with diabetes.

Expand Your Business with Arlak Corazon’s PCD Pharma Franchise Opportunities

Arlak Corazon stands tall among the rapidly growing Cardiac and Diabetic PCD Pharma Companies in India. All the products are formulated using superior quality raw materials and follow world-class manufacturing standards. Their Research and Development department has extensive experience in development and working with the WHO, GMP, ISO, FDA, and other market approvals. Monopoly or distribution rights are a key reason for the high profitability of the PCD pharma franchise business. A List of Key features is mentioned below of choosing Arlak Corazon, for PCD Pharma Franchise Business Opportunities.

• Exclusive Monopoly Rights 
• A wide range of WHO, ISO, and GMP-accredited products. 
• Premium Packaging with Timely delivery of the products.
• Ensure patient safety and efficacy
• Strong brand presence in the cardiac-diabetic segment.

What are the Possible Side Effects of Using Voglibose and Repaglinide Tablets?

Understanding the potential adverse effects of these tablets is crucial for ensuring safe and effective treatment.

A list of possible side effects has been highlighted as follows:

• Hypoglycemia (low blood glucose level)
• Abdominal pain
• Diarrhea
• Flatulence
• Headache
• Constipation

Safety Measures and Precautions

Some Precautions and safety measures have to be followed while taking this medication. Disclose your previous or recent health issues to your healthcare provider.

A List of Precautions has been mentioned as follows: 

• This Medication is not recommended for type 1 diabetes or kidney-impaired patients. 
• Pregnant or breastfeeding women should consult their doctor before use.
• These tablets should be used with caution in patients with liver disease.
• Take this medicine in the dose and duration as advised by your doctor.
• Avoid skipping meals, as it may increase the risk of hypoglycemia.

Storage Instructions for Voglibose and Repaglinide Tablets? 

Follow the instructions mentioned below as follows: 

• Store in a cool, dry place. 
• Place it away from direct sunlight.
• Keep out of reach of children.
• Do not use after the expiry date. 

Frequently Asked Questions (FAQ’s)

1. What should I do if I miss a dose?

If you forget a dose, take it with your meal. If you have already finished your meal, skip the missed dose and continue with your next scheduled dose.

2. Can this medication be taken on an empty stomach?

No, it should be taken before meals to be effective.

3. Are there any specific dietary instructions?

Follow the diet and exercise plan advised by your doctor.